KaNDy Therapeutics Alternatives & Competitors

12 companies similar to KaNDy Therapeutics — KaNDy Therapeutics develops NT-814 for treating female hormone-related condition...

Palatin Technologies

We discover and develop novel therapeutics for patients living with inflammatory and autoi...

50 Post-IPO Equity $133.90M

Biotechnology Health Care +1

Trimel Pharmaceuticals

Pioneering innovative solutions for male hypogonadism, female sexual dysfunction, and resp...

Post-IPO Equity $72.45M

Biotechnology Health Care

BioSante Pharmaceuticals

Pioneering advancements in female sexual health, menopause, contraception, and male hypogo...

Post-IPO Equity $18.00M

Biotechnology Health Care +1

The Healthy Choice Compounding Pharmacy

DEDICATE. EDUCATE. CREATE.

United States

Biotechnology Health Care

Track all KaNDy Therapeutics competitors

Get real-time alerts when any of these companies raise funding, hire, or show growth signals.

See how it works

Lumos Pharma

Transforming Lives with Rare Focus

47 Series B $53.50M

Austin, United States

Biopharma Biotechnology +2

Vira Health

Support your employees wherever they are. Global care for your workforce across all life’s...

47 Series A $10.70M

London, United Kingdom

Health Care Health and Wellness +1

HAVAH Therapeutics

Developing prevention and early treatment options for hormonally driven breast cancer and...

5 Venture round $1.51M

Australia

Biotechnology Health Care +1

Velbiom Probiotics

India’s 1st Exclusively Probiotics Company | House of Probiotics | Strain Specific | Site...

Bengaluru, India

E-Commerce Health Care +2

Atossa Therapeutics

Providing innovative treatments for pre-cancerous breast conditions and early-stage breast...

51-200 Post-IPO Equity $57.80M

Biotechnology Health Care +1

Beyond Air®

The Magic of Breathing®

79 Post-IPO Equity $85.21M

Garden City, United State...

Biopharma Biotechnology +3

OXOLIFE

Enhancing embryo implantation. Improving women’s fertility

11 Grant $2.50M

Barcelona, Spain

Biotechnology Health Care

PRAEVENTIX LLC

Pioneering the future of healthcare by developing innovative therapies for bowel, dermatol...

1 Venture round $4.32M

Biotechnology Health Care +1

About KaNDy Therapeutics

KaNDy Therapeutics, founded in 2017, prioritizes the development of NT-814 to address prevalent female sex-hormone linked disorders, specifically targeting menopause-related symptoms. The company's last investment of £25.00M in Series C funding on 29 August 2018 garnered support from a notable consortium of investors i...

Taxonomy

Therapeutics, Female Health, Menopause, Hormone-related Conditions, Clinical Stage Development, Non-hormonal Therapy, Post-menopausal Symptoms, Bio-technical Research, Treatment, Vasomotor Symptoms

Frequently Asked Questions

Companies similar to KaNDy Therapeutics include Palatin Technologies, Trimel Pharmaceuticals, BioSante Pharmaceuticals, The Healthy Choice Compounding Pharmacy, Lumos Pharma. They work in Biotechnology and Health Care and share KaNDy Therapeutics's focus on therapeutics.

Bounce Watch lists 12 companies that share KaNDy Therapeutics's industries and are closest to it in business tags, services, target customers, business model and size.

Don't just read about them. Follow them.

BounceWatch watches KaNDy Therapeutics and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.

See how it works

Explore Related

KaNDy Therapeutics Profile Palatin Technologies Alternatives Lumos Pharma Alternatives Vira Health Alternatives All Companies All Signals Trend Reports

Compiled from the BounceWatch company index. We last looked at KaNDy Therapeutics on 11 Sep 2024. The 12 companies listed here were last checked between 11 Sep 2024 and 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.